Poster Session 2: GVH/GVL
Poster Abstracts
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)
Endoscopy Biopsy in Different Sites for the Diagnosis of Lower and Upper Gastrointestinal Graft-Versus-Host Disease
Morgani Rodrigues, Hospital Israelita Albert Einstein;
Erika MM Costa, Hospital Israelita Albert Einstein;
Alessandro de Moura Almeida, Hospital Israelita Albert Einstein;
Reijane Alves de Assis, Hospital Israelita Albert Einstein;
Fernanda Nazare Cardoso Santos, Hospital Israelita Albert Einstein;
Erika Abdon Oliveira, Hospital Israelita Albert Einstein;
Denise da Cunha Pasqualin, Hospital Israelita Albert Einstein;
Alanna MPS Bezerra, Hospital Israelita Albert Einstein;
Iracema Esteves, Hospital Israelita Albert Einstein;
Karine SN Barroso, Hospital Israelita Albert Einstein;
Fabio R. Kerbauy, MD, Hospital Israelita Albert Einstein;
Jose Mauro Kutner, Hospital Israelita Albert Einstein;
Andreza Feitosa Ribeiro, PhD, Hospital Israelita Albert Einstein;
Jairo J. N. Sobrinho, MD, Hospital Israelita Albert Einstein;
Margareth Torres, DOCTOR, LIG Laboratorio de Imunogenética;
Juliana Fernandes, Hospital Israelita Albert Einstein;
Arnaldo Ganc, Hospital Israelita Albert Einstein;
Nelson Hamerschlak, MD, PhD, Hospital Israelita Albert Einstein
Factors Affecting the Incidence of Severe (Stage 2-4) Gastrointestinal (GI) Graft-Versus-Host Disease (GVHD) in Adult Patients (pts) Undergoing Allogeneic Hematopoietic Transplant (Allo-HCT) for Hematologic Malignancy
Jeffrey Betcher, R.Ph, Mayo Clinic in Arizona;
Yu-Hui Chang, MPH, Ph.D., Mayo Clinic in Arizona;
Pierre Noel, MD, Mayo Clinic Arizona;
Jose Leis, MD, PhD, Mayo Clinic Arizona;
Lisa Ostrosky Sproat, MD, MSW, Mayo Clinic Arizona;
Veena Fauble, MD, Mayo Clinic Arizona;
Nandita Khera, MD, Mayo Clinic Arizona;
Roberta Adams, MD, Mayo Clinic Arizona;
James L. Slack, MD, Mayo Clinic Arizona
Clinical Features of Cutaneous Pre-Engraftment Syndrome in Patients Receiving Umbilical Cord Blood Stem Cell Transplantation
Amanda Champlain, MD, Northwestern University Feinberg School of Medicine;
Olga Frankfurt, MD, Robert H. Lurie Comprehensive Cancer Center;
Dennis West, PhD, Northwestern University Feinberg School of Medicine;
Pedram Gerami, MD, Robert H. Lurie Comprehensive Cancer Center;
Joan Guitart, MD, Robert H. Lurie Comprehensive Cancer Center;
Jayesh Mehta, MD, Northwestern University Feinberg School of Medicine;
Jonathan Cotliar, MD, Northwestern University Feinberg School of Medicine
Immune Profiling to Predict Treatment Response from Extracorporeal Photopheresis in Graft-Versus-Host Disease
Stefan Cordes, M.D.Ph.D., Mayo Clinic;
Deepti Warad, M.D., Mayo Clinic;
Michael Gustafson, Ph.D., Mayo Clinic;
Adam Armstrong, Mayo Clinic;
Gregory Butler, Mayo Clinic;
Mrinal Patnaik, MD, Mayo Clinic;
William Hogan, MBBCh, Mayo Clinic;
Mark R Litzow, MD, Mayo Clinic;
Jeffrey Winters, M.D., Mayo Clinic;
Dennis Gastineau, MD, Mayo Clinic;
Allan Dietz, Ph.D., Mayo Clinic;
Yi Lin, M.D.Ph.D., Mayo Clinic;
Eapen K Jacob, M.D., Mayo Clinic
Using Lymphocyte Phenotypes to Predict Successful Responses to Extracorporal Photopheresis (ECP) in Patients Suffering from Chronic GvHD
Jignesh Dalal, MD, Children's Mercy Hospital;
Thomas Yankee, PhD, University of Kansas Medical Center;
Ashraf Hassaballa, MD/PhD, Kansas University Medical Center;
Bruce Parker, BS, Kansas University Medical Center;
Anne Hirner, RN, University of Kansas Hospital;
Jennifer Bunch, University of Kansas Medical Center;
Joseph McGuirk, DO, University of Kansas Medical Center;
Sunil Abhyankar, MD, University of Kansas Medical Center
Chronic Graft Versus Host Disease Presenting As Nephrotic Syndrome
Binod Dhakal, MD, Medical College of Wisconsin;
Eric P. Cohen, MD, Medical College of Wisconsin;
Jeanne Palmer, MD, Medical College of Wisconsin;
Parameswaran N. Hari, MD, MRCP, MS, CIBMTR / Medical College of Wisconsin
Improved Overall Survival in Patients with Grade III and IV Acute Graft-Versus-Host Disease
Areej El-Jawahri, MD, Dana-Farber Cancer Institute;
Shuli Li, Dana-Farber Cancer Institute;
Erin Coughlin, Massachusetts General Hospital;
Vincent T. Ho, MD, Dana Farber Cancer Institute;
Edwin P. Alyea III, MD, Dana-Farber Cancer Institute;
Philippe Armand, MD, PhD, Dana-Farber Cancer Institute;
Karen K. Ballen, MD, Massachusetts General Hospital;
Bimalangshu R Dey, MD, PhD, Massachusetts General Hospital;
Brett Glotzbecker, MD, Dana-Farber Cancer Institute;
John Koreth, MBBS, DPhil, Dana-Farber Cancer Institute;
Steven L. McAfee, MD, Massachusetts General Hospital;
Thomas R. Spitzer, MD, Massachusetts General Hospital;
Robert J. Soiffer, MD, Dana-Farber Cancer Institute;
Joseph H Antin, MD, Dana-Farber Cancer Institute;
Corey S. Cutler, MD, Dana-Farber Cancer Institute;
Yi-Bin Chen, MD, Massachusetts General Hospital
Confounding Factors Affecting the National Institutes of Health (NIH) Chronic GVHD Organ-Specific Score and Global Severity
Sahika Zeynep Aki, MD, Fred Hutchinson Cancer Research Center;
Yoshihiro Inamoto, MD, Fred Hutchinson Cancer Research Center;
Barry E. Storer, PhD, Fred Hutchinson Cancer Research Center;
Paul A. Carpenter, MD, Fred Hutchinson Cancer Research Center;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center;
Paul J. Martin, MD, Fred Hutchinson Cancer Research Center;
Mary E.D. Flowers, MD, Fred Hutchinson Cancer Research Center
Establishment of Xenogeneic Lung Chronic Graft-Verus-Host Disease Mice Model
Hisaki Fujii, MD, PhD, The Hospital for Sick Children;
Zhijuan Luo, MD, The Hospital for Sick Children;
Susan Newbigging, MSc, DVM, DVSc, Toronto Centre for Phenogenomics;
Xinghua Wang, MD, Princess Margaret Hospital;
Armand Keating, MD, Princess Margaret Hospital, University of Toronto;
R. Maarten Egeler, MD, PhD, The Hospital for Sick Children
GRAFT-Versus-Host Disease Clinical Profile and Duration of Immunosuppression Among Patients WHO Received Cord Blood STEM CELL Transplant: A Single Center Experience
Vaneuza Araujo Moreira Funke, MD, MS, Federal University of Parana;
Diogo Kloppel, MD, Federal University of Parana;
Andresa Melo, MD, Federal University of Parana;
Lisandro Ribeiro, MD, Federal University of Parana;
Carmem Bonfim, MD, Federal University of Parana;
Elenaide Coutinho Nunes Sr., MD, Nossa Senhora das Graças Hospital;
Caroline Sola, Hospital De Clinicas Da Ufpr;
Daniela C. Setubal, MD, Federal University of Parana;
Samir Nabhan, MD, Federal University of Parana;
Michel Michels Oliveira, MD, Federal University of Parana;
Ricardo Pasquini, MD, Federal University of Parana;
Mariester Malvezzi, MD. MS, Federal University of Parana
Vitamin D Deficiency Predicts Acute Cutaneous Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Alex Ganetsky, PharmD, Hospital of the University of Pennsylvania;
Lee P Richman, BA, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania;
Noelle V. Frey, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania;
Robert H Vonderheide, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania;
David L. Porter, MD, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania;
Ran Reshef, MD, Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania
Differences Between Gvhd and GVL May be Rather Quantitative and Not Dependent on a Malignant Transformation of the Target Cell
Martin Gramatzki, MD, Division of Stem Cell Transplantation and Immunotherapy;
Andreas Guenther, M.D., Division of Stem Cell Transplantation and Immunotherapy;
Natalie Schub, M.D., Division of Stem Cell Transplantation and Immunotherapy;
Michael Kneba, M.D., University of Kiel;
Andreas Humpe, M.D., Division of Stem Cell Transplantation and Immunotherapy
Ocular Gvhd: Epidemiology, Risk Factors and Impact on Quality of Life-a Chronic Gvhd Consortium Study
Madan H. Jagasia, MD, MBBS, MS, Vanderbilt University Medical Center;
Xiaoyu Chai, MS, Clinical Research Division, Fred Hutchinson Cancer Research Center;
Joseph Pidala, MD, MS, H. Lee Moffitt Cancer Center and Research Institute;
Yoshihiro Inamoto, MD, Fred Hutchinson Cancer Research Center;
Mukta Arora, MD, MS, University of Minnesota;
Corey S. Cutler, MD, Dana-Farber Cancer Institute;
Mary E.D. Flowers, MD, Fred Hutchinson Cancer Research Center;
Laura Johnston, MD, Stanford University Medical Center;
Steven Z. Pavletic, MD, National Cancer Institute;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center
In Silico Derivation of HLA-Specific Alloreactivity Potential from Whole Exome Sequencing of Stem Cell Transplant Donor-Recipient Pairs
Maximilian Jameson-Lee, PhD, VCU;
Vishal N Koparde, PhD, VCU Massey Cancer Center;
Juliana K Sampson, PhD, VCU Center for the Study of Biological Complexity;
Allison F Scalora, MS, VCU Massey Cancer Center;
Haniya Khalid, BS, VCU Massey Cancer Center;
Nihar Sheth, MS, VCU Center for the Study of Biological Complexity;
Phil Griffith, MS, VCU;
Myrna G Serrano, PhD, VCU Center for the Study of Biological Complexity;
Vladimir Lee, PhD, VCU Massey Cancer Center;
Catherine H. Roberts, PhD, VCU Massey Cancer Center;
Michael C Neale, PhD, VCU;
Gregory A Buck, PhD, VCU Center for the Study of Biological Complexity;
Masoud Manjili, PhD, VCU Massey Cancer Center;
Amir Ahmed Toor, MD, VCU Massey Cancer Center
CD8-Predominant T Cell Meningitis Accompanies Gvhd in Primates and Is Prevented with Immunoprophylaxis
Saravanan Kaliyaperumal, Harvard University Medical School;
Prachi Sharma, Emory University;
Benjamin K. Watkins, MD, Emory University;
Scott N Furlan, MD, Seattle Children's Research Institute;
Swetha Ramakrishnan, Emory University;
Cynthia Giver, Emory University;
Anapatricia Garcia, Emory University;
Cynthia Courtney, Emory University;
Kelly Hamby, Emory University;
Aneesah Garrett, Emory University;
Taylor Deane, Emory University;
Elizabeth Strobert, Yerkes National Primate Research Center;
Joe Jenkins, Emory University;
Eric Elder, Emory University;
Natia Eishiavielli, Emory University;
Timothy Crenshaw, Emory University;
Bruce R. Blazar, MD, University of Minnesota;
Edmund K. Waller, MD, PhD, Emory University;
Susan Westmoreland, VMD, New England Primate Research Center;
Leslie S. Kean, MD, PhD, Emory University
Prevalence of Joint Deficit Among Chronic Gvhd Patients Who Do Not Manifest Cutaneous or Fascial Sclerosis
Zoya Kuzmina, MD, National Institutes of Health, National Cancer Institute NCI;
Galen O Joe, MD, National institutes of Health,;
Kristin Baird, MD, National Cancer Institute, NIH;
Edward W Cowen, MD, National Cancer Institute, NIH;
Haley Bharat Naik, MD, National Cancer Institute, National Institutes of Health;
Seth Steinberg, PhD, Center for Cancer Research, National Cancer Institute, National Institutes of Health;
Leora Comis, MPA, OTR/L, FAOTA, National Institutes of Health;
Judy L Baruffaldi, National Cancer Institute, NIH;
Daniele Avila, CRNP, National Cancer Institute, NIH;
Tiffani Taylor, PA-C, National Cancer Institute, NIH;
Kristen Cole, RN, BSN, OCN, National Cancer Institute, NIH;
Sandra Mitchell, PhD, CRNP, National Institutes of Health;
Steven Z. Pavletic, MD, National Cancer Institute
Regulatory B Cells Deficiency in Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease
Zoya Kuzmina, MD, National Cancer Institute, NIH;
Jeremy J Rose, National institute of Health, National Cancer Institute NCI;
Kristin Baird, MD, National Cancer Institute, NIH;
Haley Bharat Naik, MD, National Cancer Institute, National Institutes of Health;
Edward W Cowen, MD, National Cancer Institute, NIH;
Steven Z. Pavletic, MD, National Cancer Institute;
Fran Hakim, PhD, NCI
Children with Gut Acute Graft Versus Host Disease (aGVHD) Following Allogeneic Stem Cell Transplant (AlloHCT) Have an Increased Incidence of Enteric Bacteria Blood Stream Infections (EB-BSI)
Anya Levinson, Columbia University;
Kerice Pinkney, New York-Presbyterian Morgan Stanley Children’s Hospital;
Zhezhen Jin, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Marc Foca, Columbia University;
James Garvin, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University
Complement Component C3 Mediates Th1/Th17 Polarization in Human T Cell Activation and Cutaneous Graft-Versus-Host Disease
Qing Ma, PhD, M.D. Anderson Cancer Center;
Dan Li, University of Texas M.D. Anderson Cancer Center;
Amin M. Alousi, MD, UT MD Anderson Cancer Center;
Richard E. Champlin, MD, UT MD Anderson Cancer Center;
George E Sale, MD, Fred Hutchinson Cancer Rsrch Univ Wash;
Vahid Afshar-Kharghan, University of Texas M.D. Anderson Cancer Center
Diagnostic Criteria for Myositis As a Facet of Chronic Gvhd
Muhammad Mir, MBBS, Mayo Clinic;
Shahrukh Hashmi, MD, Mayo Clinic;
Mrinal Patnaik, MD, Mayo Clinic;
William Hogan, MBBCh, Mayo Clinic;
Mark R Litzow, MD, Mayo Clinic
Impact of Conditioning Intensity with or without Total Body Irradiation on Acute Graft-Versus-Host Disease and Clinical Outcomes
Hideki Nakasone, MD, PhD, Saitama Medical Center, Jichi Medical University;
Takahiro Fukuda, MD, National Cancer Center Hospital;
Junya Kanda, MD, PhD, Saitama Medical Center, Jichi Medical University;
Takehiko Mori, Keio University School of Medicine;
Takanori Teshima, MD, Hokkaido University Graduate School of Medicine;
Shingo Yano, Jikei University School of Medicine;
Naoyuki Uchida, MD, Toranomon Hospital;
Kazuhiko Kakihana, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital;
Tetsuya Eto, Hamanomachi Hospital;
Shin-Ichiro Mori, MD, St Luke's International Hospital;
Tokiko Nagamura, MD, PhD, Institute of Medical Science, University of Tokyo;
Tatsuo Ichinohe, Kyoto University;
Yoshiko Atsuta, MD, PhD, Nagoya University Graduate School of Medicine;
Makoto Murata, Nagoya University Graduate School of Medicine
Monitoring of GRAFT Versus Leukemia Effect with CD34+ Specific DONOR Chimerism Analysis
Maxim Norkin, MD, University of Florida;
Christopher Ramin Cogle, MD, University of Florida;
Helen Leather, BPharm, HLL Communications;
Amy Meacham, University of Florida;
Emma Rosenau, Shands Hospital;
Jan S. Moreb, MD, University of Florida;
Jack W. Hsu, MD, University of Florida;
John W Hiemenz, MD, University of Florida;
William S May, University of Florida;
John R. Wingard, MD, University of Florida
Close Monitoring of Cyclosporine A Concentration as a Means of Preventing Acute Graft-Versus-Host Disease in Allogeneic Stem Cell Recipients
Marietta Nygaard, MD, Rigshospitalet, Copenhagen University Hospital;
Doris Hovgaard, MD, Rigshospitalet, Copenhagen University Hospital;
Ida Schjødt, MD, PhD, Rigshospitalet, Copenhagen University Hospital;
Niels Smedegaard, MD, DMSc, Rigshospitalet, Copenhagen University Hospital;
Lars Vindeløv, MD, DMSc, Rigshospitalet, Copenhagen University Hospital;
Henrik Sengeløv, MD, DMSc, Rigshospitalet, Copenhagen University Hospital
The Impact of Subtherapeutic Tacrolimus Levels on the Incidence of Acute Graft-Versus Host-Disease (aGVHD) in Children Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) – Redefining the Target Range
Katharine Offer, Columbia University;
Michelle Kolb, New York-Presbyterian Morgan Stanley Children’s Hospital;
Zhezhen Jin, PhD, Columbia University;
Monica Bhatia, MD, Columbia University;
Andrew Kung, MD, PhD, Columbia University;
Diane George, MD, Columbia University;
James Garvin, MD, PhD, Columbia University;
Prakash Satwani, MD, Columbia University
Epidemiology of Chronic Graft-Versus-Host Disease in the Pediatric Recipients of Hematopoietic Stem Cell Transplantation
Kris Michael Mahadeo, MD, MPH, Children's Hospital Los Angeles;
Neena Kapoor, MD, Children's Hospital Los Angeles;
Ami J Shah, MD, Children's Hospital Los Angeles;
Hisham Abdel-Azim, MD, Children's Hospital Los Angeles;
Robertson Parkman, MD, Children's Hospital Los Angeles
High Day 28 ST2 Biomarker Levels Predict Severe Day 100 Acute Graft-Versus-Host Disease and Day 180 Transplant-Related Mortality after Double-Unit Cord Blood Transplantation
Doris M. Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Patrick Hilden, PhD, Memorial Sloan-Kettering Cancer Center;
Christie Mumaw, MS, Indiana University;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Susan E. Prockop, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Katharine Hsu, MD PhD, Memorial Sloan-Kettering Cancer Center;
Marcel R. M. van den Brink, MD, PhD, Memorial Sloan-Kettering Cancer Center;
James W Young, MD, FACP, Memorial Sloan-Kettering Cancer Center;
Sophie Paczesny, MD, PhD, Indiana University;
Juliet N. Barker*, MBBS, (Hons), FRACP, Memorial Sloan-Kettering Cancer Center
Intensified Mycophenolate Mofetil (MMF) Dosing Is Safe from the Standpoint of Engraftment and Reduces Severe Acute Graft-Versus-Host Disease (aGVHD) after Double-Unit Cord Blood Transplantation (DCBT): An Analysis of 173 Patients
Doris M. Ponce, MD, Memorial Sloan-Kettering Cancer Center;
Stephen Harnicar, PharmD, BCOP, BCPS, Memorial Sloan-Kettering Cancer Center;
Patrick Hilden, PhD, Memorial Sloan-Kettering Cancer Center;
Sean Devlin, PhD, Memorial Sloan-Kettering Cancer Center;
Katherine Evans, BA, Memorial Sloan-Kettering Cancer Center;
Marissa Lubin, BA, Memorial Sloan-Kettering Cancer Center;
Nancy Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Susan E. Prockop, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center;
Jenna D. Goldberg, MD, Memorial Sloan-Kettering Cancer Center;
Miguel-Angel Perales, MD, Memorial Sloan-Kettering Cancer Center;
Juliet N. Barker, MBBS, FRACP, Memorial Sloan-Kettering Cancer Center
Sclerodermatous Chronic Gvhd in Patients Receiving Tyrosine Kinase Inhibitors after Allogeneic Hematopoeitic Stem Cell Transplant
Amandeep Salhotra, MD, City of Hope;
Joycelynne Palmer, PhD, City of Hope;
Ni-Chun Tsai, MS, MPH, City Of Hope;
Tanya Paris, City of Hope;
Pablo M Parker, MD, City of Hope National Med Ctr;
Stephen J. Forman, MD, City of Hope National Medical Center;
Ryotaro Nakamura, MD, City of Hope
IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ-Dependent and Fas-Supported Apoptosis of Alloreactive CD4+ T Cells and Inhibit Graft-Versus-Host Disease
Elizabeth Stenger, MD, Children's Healthcare of Atlanta;
Brian Rosborough, PhD, University of Pittsburgh;
Lisa Mathews, University of Pittsburgh;
Hui Hui Ma, MD PhD, Columbia University;
Markus Y Mapara, MD, PhD, Columbia University;
Angus W. Thomson, PhD, University of Pittsburgh;
Heth Turnquist, PhD, University of Pittsburgh
Trametinib Selectively Inhibits Alloreactivity While Sparing Virus-Specific T Cells
Eric Wieder, PhD, University of Miami;
Despina Kolonias, Sylvester Comprehensive Cancer Center;
Cara Benjamin, PhD, Sylvester Cancer Center - University of Miami;
Takero Shindo, MD, Kyoto University, Graduate School of Medicine;
Tae Kon Kim, MD, PhD, Yale University;
Robert B Levy, PhD, U of Miami Schl of Med Micrbio/Imm;
Krishna Komanduri, MD, University of Miami
Cannabidiol – an Innovative Strategy for Graft Versus Host Disease Prevention – an Update of a Phase I/II Study
Moshe Yeshurun, MD, Rabin Medical Center;
Ofer Shpilberg, MD, Sackler School of Medicine;
Maly Levy-Assaraf, PhD, Sackler School of Medicine;
Korina Herscovici, MD, Sackler School of Medicine;
Juliet Dreyer, RN, Sackler School of Medicine;
Anat Peck, RN, Sackler School of Medicine;
Moshe Israeli, PhD, Rabin Medical Center;
Galit Granot, PhD, Felsenstein Medical Research Center;
Tsipora Gruenewald, M.Ph.Sc, Rabin Medical Center;
Rafael Mechoulam, PhD, Hebrew University;
Ron Ram, MD, Sackler School of Medicine
